TRISOMY-12 IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - CORRELATION WITH ADVANCED DISEASE, ATYPICAL MORPHOLOGY, HIGH-LEVELS OF SCD25, AND WITH REFRACTORINESS TO TREATMENT

被引:22
作者
KNAUF, WU
KNUUTILA, S
ZEIGMEISTER, B
THIEL, E
机构
[1] Dept. of Hematology and Oncology, Klinikum Benjamin Franklin, Free Universtiy of Berlin, Berlin
关键词
TRISOMY; 12; CHRONIC LYMPHOCYTIC LEUKEMIA; IN SITU HYBRIDIZATION; SOLUBLE CD25; DISEASE ACTIVITY;
D O I
10.3109/10428199509107900
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In situ hybridization was performed to study the clinical significance of trisomy 12 in fifty patients with B-cell chronic lymphocytic leukemia at various stages of disease. Trisomy 12 was detected in 12%-65% (median 53%) of the circulating neoplastic cells in seven out of 20 patients with advanced Binet stage C disease. In contrast, 22 patients with Binet stage A and eight patients with Binet stage B disease were found to be negative for trisomy 12. As occurrence of trisomy 12 was associated with the presence of B-symptoms and hepatosplenomegaly, its association with advanced disease was further considered. In addition, atypical morphology was a common finding in trisomic patients who also displayed higher serum levels of soluble CD25 than patients without trisomy at Binet stage C. No significant differences were detected in serum levels of soluble CD8 and of soluble CD23. No correlation with a lymphocyte doubling time of < 12 months, marked lymphadenopathy, or prior treatment was apparent. However, refractoriness to treatment was evident more frequently in trisomic than in non-trisomic patients (p < .05). In conclusion, trisomy 12 in B-cell chronic lymphocytic leukemia appears to occur predominantly in advanced and symptomatic disease with atypical morphology, It could indicate a high risk for treatment failure thus serving as a marker of poor prognosis in this disease.
引用
收藏
页码:289 / 294
页数:6
相关论文
共 34 条
  • [1] Knuutila S., Elonen E., Teerenhovi L., Rossi L., Leskinen R., Bloomfield C., de la Chapelle A., Trisomy 12 in B cells of patients with B-cell chronic lymphocytic leukemia, N. Engl. J. Med., 314, pp. 865-869, (1986)
  • [2] Juliusson G., Oscier D.G., Fitchett M., Ross F.M., Stockdill G., Mackie M.J., Parker A.C., Castoldi G.L., Cuneo A., Knuutila S., Elonen E., Gahrton G., Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities, N. Engl. J. Med., 323, pp. 720-724, (1990)
  • [3] Anastasi J., Le Beau M.M., Vardiman J.W., Fernald A.A., Larson R.A., Rowley J.D., Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescent in situ hybridization to interphase cells: a simple and sensitive method, Blood, 79, pp. 1796-1801, (1992)
  • [4] Doehner H., Pohl S., Bulgary-Moerschel M., Stilgenbauer S., Bentz M., Lichter P., Trisomy 12 in chronic lymphoid leukemias—a metaphase and interphase cytogenetic analysis, Leukemia, 7, pp. 516-520, (1993)
  • [5] Escudier S.M., Pereira-Leaky J.M., Drach J.W., Weier H.U., Goodacre A.M., Cork M.A., Trujillo J.M., Keating M.J., Andreeff M., Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia, Blood, 81, pp. 2702-2707, (1993)
  • [6] Fitchett M., Griffiths M.J., Oscier D.G., Johnson S., Seabright M., Chromosome abnormalities involving band 13q14 in hematologic malignancies, Cancer Genetics and Cytogenetics, 24, pp. 143-150, (1987)
  • [7] Oscier D.G., Fitchett M., Hamblin T.J., Chromosomal abnormalities in B-CLL, Nouvelle Revue Francaise d'Hématologie., 30, pp. 397-398, (1988)
  • [8] Juliusson G., Gahrton G., Chromosomal aberrations in B-cell chronic lymphocytic leukemia: pathogenetic and clinical implications, Cancer Genetics and Cytogenetics, 45, pp. 143-160, (1990)
  • [9] Stilgenbauer H., Dochner S., Bulgary-Moerschel M., Weitz S., Bentz M., Lichter P., High frequency of monoallelic retinoblastoma gene deletion in patients with chronic lymphoid leukemia revealed by interphase cytogenetics, Blood, 80, pp. 2118-2124, (1993)
  • [10] Perez-Losada A., Wessman M., Tiainen M., Hopman A., Willard H.F., Sole F., Caballin M.R., Woessner S., Knuutila S., Trisomy 12 in chronic lymphocytic leukemia: an interphase cytogenetic study, Blood, 78, pp. 775-779, (1991)